Reuters logo
BRIEF-Bayer Announces Initiation Of Rolling Submission Of NDA In U.S. For Larotrectinib
December 20, 2017 / 11:49 AM / a month ago

BRIEF-Bayer Announces Initiation Of Rolling Submission Of NDA In U.S. For Larotrectinib

Dec 20 (Reuters) - BAYER AG:

* INITIATION OF ROLLING SUBMISSION OF NDA IN U.S. FOR LAROTRECTINIB FOR TREATMENT OF TRK FUSION CANCERS​

* ‍COMPLETION OF NDA SUBMISSION EXPECTED IN EARLY 2018​ Source text - bit.ly/2krZBYf Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below